Back to search

Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model

Data up to Jan 2025

Published1999
Citations39
References37

Total Citations Per Year

Abstract

References (37)

Purification and Characterization of Mouse Hematopoietic Stem Cells

1988 • 2,856 citations

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1990 • 1,544 citations

Isolation of a candidate human hematopoietic stem-cell population.

1992 • 1,098 citations

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

1985 • 517 citations

Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose

1993 • 356 citations

Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease

1999 • 312 citations

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

1998 • 305 citations

Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells

1994 • 298 citations

Treatment of Donor Bone Marrow with Monoclonal Anti-T-Cell Antibody and Complement for the Prevention of Graft-Versus-Host Disease

1986 • 275 citations

Spontaneous murine B-cell leukaemia

1978 • 264 citations

Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.

1993 • 195 citations

Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.

1987 • 170 citations

Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.

1991 • 154 citations

Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia

1990 • 150 citations

Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.

1996 • 137 citations

Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.

1996 • 124 citations

The Tumor Dormant State

1981 • 123 citations

Interleukin-12 Preserves the Graft-Versus-Leukemia Effect of Allogeneic CD8 T Cells While Inhibiting CD4-Dependent Graft-Versus-Host Disease in Mice

1997 • 110 citations

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection.

1994 • 106 citations

BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor

1979 • 95 citations

Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments]

1994 • 93 citations

Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia

1990 • 89 citations

Graft vs. Host Disease

2004 • 75 citations

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1990 • 71 citations

Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.

1992 • 67 citations

Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.

1979 • 64 citations

Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.

1986 • 64 citations

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

1985 • 58 citations

Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice

1997 • 56 citations

In vitro and in vivo analysis of bone marrow-derived CD3+, CD4−, CD8−, NK1.1+ cell lines

1990 • 55 citations

Donor Lymphocyte Infusion for the Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

1998 • 50 citations

Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.

1983 • 49 citations

Murine B Cell Leukemia (BCL1): Organ Distribution and Kinetics of Growth as Determined by Fluorescence Analysis with an Anti-Idiotypic Antibody

1979 • 43 citations

The Pathology and Homing of a Transplantable Murine B Cell Leukemia (BCL1)

1979 • 37 citations

11 Donor leukocyte infusions

1997 • 24 citations

THE EFFECT OF HUMAN IL-2-ACTIVATED NATURAL KILLER AND T CELLS ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA IN SCID MICE BEARING HUMAN LEUKEMIC CELLS

1995 • 23 citations

Evidence for a possible role of Asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia.

1995 • 22 citations

Cited By (0)

Loading...
Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model (1999) – Biology of Blood and Marrow Transplantation | Metascience Observatory Explorer